To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105
Clinical trial NCT06754943 · COMPLETED
Trial details
- NCT number
- NCT06754943
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-17
- Primary completion
- 2025-03-24
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.